Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study

Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study

Background: Inflammation has been linked to prostate cancer and hypertension, but it remains equivocal whether elevated blood pressure (BP) influence prostate cancer risk and survival. Method: Using Cox regression models, we examined the association between prediagnostic BP and prostate cancer risk...

Full description

Bibliographic Details
Main Authors: Eggen, A.E (Author), Giovannucci, E.L (Author), Haugnes, H.S (Author), Knutsen, T. (Author), McTiernan, A. (Author), Richardsen, E. (Author), Schirmer, H. (Author), Stikbakke, E. (Author), Støyten, M. (Author), Thune, I. (Author), Wilsgaard, T. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2022
Subjects:
hypertension
inflammation
mortality
prostate cancer
risk
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items